BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
57.23
+0.53 (0.93%)
Nov 13, 2026, 4:00 PM EST - Market closed
BioMarin Pharmaceutical Employees
BioMarin Pharmaceutical had 3,221 employees as of December 31, 2025. The number of employees increased by 181 or 5.95% compared to the previous year. That makes BioMarin Pharmaceutical the 7,594th largest employer in the world and 1,399th in the United States.
Employees
3,221
Change (1Y)
181
Growth (1Y)
5.95%
Revenue / Employee
$1,134,780
Profits / Employee
-$5,934
Market Cap
11.09B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3,221 | 181 | 5.95% |
| Dec 31, 2024 | 3,040 | -361 | -10.61% |
| Dec 31, 2023 | 3,401 | 319 | 10.35% |
| Dec 31, 2022 | 3,082 | 37 | 1.22% |
| Dec 31, 2021 | 3,045 | -14 | -0.46% |
| Dec 31, 2020 | 3,059 | 58 | 1.93% |
| Dec 31, 2019 | 3,001 | 152 | 5.34% |
| Dec 31, 2018 | 2,849 | 268 | 10.38% |
| Dec 31, 2017 | 2,581 | 288 | 12.56% |
| Dec 31, 2016 | 2,293 | 135 | 6.26% |
| Dec 31, 2015 | 2,158 | 477 | 28.38% |
| Dec 31, 2014 | 1,681 | 340 | 25.35% |
| Dec 31, 2013 | 1,341 | 252 | 23.14% |
| Dec 31, 2012 | 1,089 | 87 | 8.68% |
| Dec 31, 2011 | 1,002 | 131 | 15.04% |
| Dec 31, 2010 | 871 | 151 | 20.97% |
| Dec 31, 2009 | 720 | 71 | 10.94% |
| Dec 31, 2008 | 649 | 124 | 23.62% |
| Dec 31, 2007 | 525 | 115 | 28.05% |
| Dec 31, 2006 | 410 | 96 | 30.57% |
| Dec 31, 2005 | 314 | -45 | -12.53% |
| Dec 31, 2004 | 359 | 87 | 31.99% |
| Dec 31, 2003 | 272 | 53 | 24.20% |
| Dec 31, 2002 | 219 | 3 | 1.39% |
| Dec 31, 2001 | 216 | 42 | 24.14% |
| Dec 31, 2000 | 174 | 25 | 16.78% |
| Dec 31, 1999 | 149 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,000 |
| Madrigal Pharmaceuticals | 915 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
| TG Therapeutics | 399 |
| Krystal Biotech | 295 |
| Kymera Therapeutics | 285 |
| Summit Therapeutics | 265 |
BMRN News
- 23 hours ago - BioMarin price target lowered to $103 from $119 at Morgan Stanley - TheFly
- 2 days ago - BioMarin Pharmaceutical Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 9 days ago - BioMarin to Participate in Upcoming Investor Conferences - PRNewsWire
- 9 days ago - BioMarin price target lowered to $86 from $87 at JPMorgan - TheFly
- 10 days ago - BioMarin price target lowered to $60 from $62 at RBC Capital - TheFly
- 10 days ago - BioMarin price target lowered to $89 from $94 at Wedbush - TheFly
- 10 days ago - BioMarin price target lowered to $94 from $97 at Oppenheimer - TheFly
- 10 days ago - BioMarin price target lowered to $83 from $86 at BofA - TheFly